JPRN-UMIN000016230已完成未知
The evaluation of safty and efficacy of active-form Vitamin D application on eye lids in normal subjects and patients with meibomian gland dysfunction - The efficacy of active Vitamin D ointment application on the eye lids in meibomian gland dysfunction
Itoh clinic0 个研究点目标入组 15 人开始时间: 2015年1月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •past history of allergic reaction of active-form Vitamin D
研究者
相似试验
已完成
不适用
Assessment of the Efficacy and Safety of the Use of Perfectha Deep Lidocaine in the Treatment of Nasolabial Folds, Marionette Lines and Temple HollowingR23.4Changes in skin textureDRKS00029739Sinclair Pharmaceuticals LtdEden HouseLakeside70
已完成
不适用
Safety and efficacy of the treatment of active-form Vitamin D application for meibomian gland dysfunctiomeibomian gland dysfunctionJPRN-UMIN000029347Tokyo Dental College Ichikawa General Hospital20
进行中（未招募）
1 期
se of an antidiabetic drug (Empagliflozin) to lower the blood level of 1,5-anhydroglucitol in patients deficient in the glucose-6-phosphate transporter (GSD1b) and the phosphatase G6PC3, both of the endoplasmic reticulum, to treat their recurrent infections by normalizing their blood neutrophil counts. Neutrophils are the most abundant white blood cells in our blood that are essential to help fighting infections. 1,5-anhydroglucitol is a sugar derivative with no known function.(1) Severe Congenital Neutropenia type 4 (SNC4) due to a deficiency in G6PC3, a phosphatase of the endoplasmic also known a Ubiquitous glucose-6-phosphatase and (2) the neutropenia in Glycogen Storage Disease type 1b due to a deficiency in the glucose-6-phosphate transporter (G6PT / SLC37A4) of the endoplasmic reticulum.EUCTR2018-004191-35-BECliniques universitaires Saint-Luc5
已完成
不适用
Prospective evaluation of efficacy and safety of argon plasma coagulation therapy with submucosal injection prior to ablation in Barrett's esophagusC15.5Lower third of oesophagusDRKS00003369HSK Wiesbaden60
尚未招募
4 期
euroEPO in mild-moderate Alzheimer's disease amnesic variantmild-moderate Alzheimer's diseaseAlzheimer DiseaseBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental DisordersDementiaRPCEC00000410Center of Molecular Immunology (CIM)1,456